Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.

被引：0
|
作者：
Wu, Fang [1 ]
Wu, Sixuan [1 ]
Hu, Chunhong [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e20640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20640
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study
    Hu, Jia
    Huang, Di
    Wang, Yanrong
    Li, Donghui
    Yang, Xuejiao
    Fu, Yan
    Du, Nan
    Zhao, Yan
    Li, Xiaosong
    Ma, Junxun
    Hu, Yi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs
    Wei, Kunchen
    Zhou, Chao
    Chen, Yang
    Feng, Xiao
    Tang, Hao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs
    Wei, Kunchen
    Tang, Hao
    RESPIROLOGY, 2023, 28 : 329 - 329
  • [24] Chemotherapy plus EGFR-TKIs versus EGFR-TKIs Alone in Non-small Cell Lung Cancer with EGFR-Activating Mutations: A Meta-analysis
    Han, G.
    Peng, M.
    Weng, Y.
    Zou, J.
    Song, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E458 - E458
  • [25] The Association between SNP of EGFR and Response to EGFR-TKIs According to EGFR Mutation in Non-Small Cell Lung Cancer
    Jeon, Eun Kyoung
    Shin, Jung-Young
    Cho, Eun Kyung
    Kang, Jin-Hyoung
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S376 - S376
  • [26] EGFR Exon 20 insertion: Prognostic and predictive values in advanced non-small cell lung cancer, a real-world study.
    Chouaid, Christos
    Filleron, Thomas
    Debieuvre, Didier
    Perol, Maurice
    Girard, Nicolas
    Dansin, Eric
    Gervais, Radj
    Cousin, Sophie
    Otto, Josiane
    Schott, Roland
    Planchard, David
    Madroszyk, Anne
    Kaderbhai, Coureche
    Dubray-Longeras, Pascale
    Hiret, Sandrine
    Pichon, Eric
    Clement-Duchene, Christelle Anne
    Martin, Anne-Laure
    Simon, Gaetane
    Quantin, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
    Shi, Xiaoshun
    Dong, Xiaoying
    Zhai, Jianxue
    Liu, Xiguang
    Lu, Di
    Ni, Zhen
    Wu, Hua
    Cai, Kaican
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer
    Cheng, Hua
    Li, Xiao-Jian
    Wang, Xiao-Jin
    Chen, Zuo-Wen
    Wang, Rui-Qi
    Zhong, Hong-Cheng
    Wu, Tian-Chi
    Cao, Qing-Dong
    LUNG CANCER, 2019, 137 : 7 - 13
  • [29] Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
    Kubo, Naoki
    Harada, Taishi
    Shiraishi, Yoshimasa
    Nosaki, Kaname
    Nakagaki, Noriaki
    Takeshita, Masafumi
    Ouchi, Hiroshi
    Iwama, Eiji
    Tanaka, Kentaro
    Okamoto, Isamu
    Sasaki, Hiroyuki
    Nakanishi, Yoichi
    ANTICANCER RESEARCH, 2019, 39 (02) : 671 - 677
  • [30] Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases
    Yu, Xiaoqing
    Sheng, Jiamin
    Pan, Guoqiang
    Fan, Yun
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1121 - 1128
12345